Swiss digital health startup Hilo, formerly known as Aktiia, has secured €36.3 million (CHF 34 million) in a Series B funding round.
The investment was co-led by Earlybird Venture Capital and Wellington Partners, with participation from Kfund, naturalX Health Ventures, and existing backers Khosla Ventures, Molten Ventures, redalpine, Verve Ventures, and Translink Capital.
Founded in 2018, Hilo is pioneering continuous, cuffless blood pressure monitoring through wearable sensors and optical technologies. Its platform delivers real-time insights to both patients and physicians, replacing traditional cuff-based methods that limit the frequency of monitoring.
Advertisement
Built on 15 years of research
The firm’s core technology stems from over a decade of research at the Swiss Centre for Electronics and Microtechnology (CSEM) by co-founders Mattia Bertschi and Josep Sola. The company claims it offers the first major innovation in hypertension tracking in more than 20 years.
Unlike conventional solutions, Hilo’s system continuously collects and analyzes blood pressure data, enabling early diagnosis and improved long-term management of cardiovascular conditions.
Expansion plans and capital allocation
The company will use the newly raised capital to:
- Expand global availability of its cuffless monitoring tools
- Strengthen enterprise and healthcare partnerships
- Advance R&D into new optical sensing technologies, including smartphone camera-based monitoring
- Grow its team across the US and Europe
With a mission to empower 100 million people to better manage blood pressure by 2032, the company is actively hiring and ramping up product deployment. It currently operates remotely, with headquarters in Switzerland and a distributed workforce of 60 employees.
Rebranding and future roadmap
In April 2025, the company rebranded from Aktiia to Hilo to reflect its broader healthtech vision and updated product roadmap. Despite the new name and visual identity, Hilo will continue offering the same advanced analytics platform, combining real-time tracking with actionable health insights.
By making blood pressure monitoring more accessible, frequent, and intelligent, the healthtech startup aims to reduce cardiovascular risks globally — and become the go-to platform for managing one of the world’s most common chronic conditions.
